TP53 and cancer: Taken together, these findings demonstrate that ablation of endogenous SBDS suppresses cancer cell proliferation and invasion partially through the RP-MDM2–p53 signaling pathway, but its long-term deficiency is more detrimental to cell survival owing to its essential role in ribosome biogenesis.